IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, W.-C.
Right arrow Articles by Tsao, Y.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, W.-C.
Right arrow Articles by Tsao, Y.-P.
(Investigative Ophthalmology and Visual Science. 2002;43:3480-3488.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Gene Therapy for Detached Retina by Adeno-Associated Virus Vector Expressing Glial Cell Line–Derived Neurotrophic Factor

Wei-Chi Wu1, Chi-Chun Lai1, Show-Li Chen2, Xiao Xiao3, Tun-Lu Chen1, Ray Jui-Fang Tsai1, Shu-Wen Kuo4 and Yeou-Ping Tsao1

1 From the Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; the 2 Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan; the 3 Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, Pennsylvania; and the 4 Department of Medical Research, Veteran’s General Hospital, Taipei, Taiwan.

PURPOSE. To examine the protective effect of glial cell line–derived neurotrophic factor (GDNF) on retinal detachment (RD)–induced photoreceptor damage by using gene delivery.

METHODS. Gene delivery to photoreceptors was achieved by subretinal injection of recombinant adeno-associated virus expressing GDNF (rAAV-GDNF) in the right eyes and AAV expressing Escherichia coli LacZ (rAAV-LacZ) in the left eyes of Lewis rats. RD in bilateral eyes was induced with subretinal injection of high-density vitreous substitute in the temporal retina 3 weeks after gene delivery. The synthesis and accumulation of GDNF within the retina was monitored 3 weeks after RD by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA), respectively. The rescue of photoreceptors was evaluated by monitoring the preservation of the thickness of photoreceptor outer segment (OS) and outer nuclear layer (ONL). Apoptosis in the photoreceptors was studied using the TdT-dUTP terminal nick-end labeling (TUNEL) method 2 days after RD. Müller cell activity was checked using the immunohistochemistry with glial fibrillary acidic protein (GFAP) antibody 28 days after RD.

RESULTS. Gene delivery was demonstrated by immunohistochemical study. The results of ELISA confirmed that high levels of neurotrophic factors were produced in retinas. Photoreceptor OS degeneration and the gradual shortening of the ONL were noted after RD in all the eyes. However, rAAV-GDNF–treated eyes retained longer OS than rAAV-LacZ–treated eyes 7 (P = 0.012) and 28 days (P = 0.008) after RD. ONL was also longer in rAAV-GDNF–treated eyes than in rAAV-LacZ–treated eyes 7 (P = 0.012) and 28 days (P = 0.008) after RD. GDNF-treated eyes had statistically less apoptotic cells than control eyes in photoreceptor layer (P = 0.043). Subretinal proliferation of Müller cells was suppressed in the GDNF-treated group, indicating less scar formation.

CONCLUSIONS. GDNF is a potential factor that can protect photoreceptors from degeneration. In addition to preserving the OS and ONL structures, GDNF may exert its protective action by preventing the apoptosis of photoreceptors after RD. GDNF gene therapy may be a valuable adjuvant to current treatments in certain complicated forms of RD.




This article has been cited by other articles:


Home page
 Stem CellsHome page
R. D. Lund, S. Wang, B. Lu, S. Girman, T. Holmes, Y. Sauve, D. J. Messina, I. R. Harris, A. J. Kihm, A. M. Harmon, et al.
Cells Isolated from Umbilical Cord Tissue Rescue Photoreceptors and Visual Functions in a Rodent Model of Retinal Disease
Stem Cells, March 1, 2007; 25(3): 602 - 611.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Yoshioka, T. Abe, R. Wakusawa, T. Moriya, S. Mochizuki, Y. Saigo, T. Saito, H. Murata, Y. Tokita, T. Iseya, et al.
Recombinant AAV-Transduced Iris Pigment Epithelial Cell Transplantation May Transfer Vector to Native RPE but Suppress Systemic Dissemination
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 745 - 752.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Hojo, T. Abe, E. Sugano, Y. Yoshioka, Y. Saigo, H. Tomita, R. Wakusawa, and M. Tamai
Photoreceptor Protection by Iris Pigment Epithelial Transplantation Transduced with AAV-Mediated Brain-Derived Neurotrophic Factor Gene
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3721 - 3726.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. M. Lawrence, D. J. Keegan, E. M. Muir, P. J. Coffey, J. H. Rogers, M. J. Wilby, J. W. Fawcett, and R. D. Lund
Transplantation of Schwann Cell Line Clones Secreting GDNF or BDNF into the Retinas of Dystrophic Royal College of Surgeons Rats
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 267 - 274.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Nour, A. B. Quiambao, W. M. Peterson, M. R. Al-Ubaidi, and M. I. Naash
P2Y2 Receptor Agonist INS37217 Enhances Functional Recovery after Detachment Caused by Subretinal Injection in Normal and rds Mice
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4505 - 4514.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology